FDA inspection
Innovative Blood Resources, a Division of New York Blood Center, Inc.: FDA inspection ending Oct 23, 2024
FDA inspection 1254117 · No Action Indicated (NAI) · Lincoln, NE
Key facts
| Inspection ID | 1254117 |
|---|---|
| Firm | Innovative Blood Resources, a Division of New York Blood Center, Inc. |
| FEI number | 1970753 |
| Address | 100 N 84th St |
| City | Lincoln |
| State | NE |
| ZIP | 68505 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Oct 23, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data